NIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigrees
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Kaufmann, Charles A.Suarez, Brian
Malaspina, Dolores
Pepple, John
Svrakic, Dragan
Markel, Paul D.
Meyer, Joanne
Zambuto, Christopher T.
Schmitt, Karin
Matise, Tara Cox
Friedman, Jill M. Harkavy
Hampe, Carol
Lee, Hang
Shore, David
Wynne, Debra
Faraone, Stephen V.
Tsuang, Ming T.
Cloninger, C. Robert
Keyword
Genetics(clinical): schizophrenia; linkage analysis; African-American; NIMH Genetics Initiative
Journal title
American Journal of Medical GeneticsDate Published
1998-07-10Publication Volume
81Publication Issue
4Publication Begin page
282Publication End page
289
Metadata
Show full item recordAbstract
The NIMH Genetics Initiative is a multi-site collaborative study designed to create a national resource for genetic studies of complex neuropsychiatric disorders. Schizophrenia pedigrees have been collected at three sites: Washington University, Columbia University, and Harvard University. This article—one in a series that describes the results of a genome-wide scan with 459 short-tandem repeat (STR) markers for susceptibility loci in the NIMH Genetics Initiative schizophrenia sample—presents results for African-American pedigrees. The African-American sample comprises 30 nuclear families and 98 subjects. Seventy-nine of the family members were considered affected by virtue of having received a DSMIII-R diagnosis of schizophrenia (n = 71) or schizoaffective disorder, depressed (n = 8). The families contained a total of 42 independent sib pairs. While no region demonstrated evidence of significant linkage using the criteria suggested by Lander and Kruglyak, several regions, including chromosomes 6q16-6q24, 8pter-8q12, 9q32-9q34, and 15p13-15q12, showed evidence consistent with linkage (P = 0.01–0.05), providing independent support of findings reported in other studies. Moreover, the fact that different genetic loci were identified in this and in the European-American samples, lends credence to the notion that these genetic differences together with differences in environmental exposures may contribute to the reported differences in disease prevalence, severity, comorbidity, and course that has been observed in different racial groups in the United States and elsewhere. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 81:282–289, 1998. © 1998 Wiley-Liss, Inc.The following license files are associated with this item:
- Creative Commons